Cadrenal Therapeutics, Inc. (CVKD)

NASDAQ: CVKD · Real-Time Price · USD

6.52

-0.45 (-6.46%)

At close: Mar 20, 2026, 4:00 PM EDT

6.48

-0.04 (-0.65%)

After-hours: Mar 20, 2026, 6:58 PM EDT

Cadrenal Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	9.7	6.75	3.55
Depreciation & Amortization Expenses	0.01	0	0
Research & Development	4.97	4.21	4.08
Total Operating Expenses	14.67	10.96	7.63
Operating Income	-14.67	-10.96	-7.63
Interest Income	0.2	0.31	0.25
Interest Expense	-	-	-0.02
Other Non-Operating Income (Expense)	-	-	-0.96
Total Non-Operating Income (Expense)	0.2	0.31	-0.72
Pretax Income	-14.48	-10.65	-8.36
Net Income	-14.39	-10.65	-8.36
Net Income to Common	-14.39	-10.65	-8.36
Shares Outstanding (Basic)	2	1	1
Shares Outstanding (Diluted)	2	1	1
Shares Change (YoY)	63.04%	35.59%	-
EPS (Basic)	-8.76	-8.73	-9.29
EPS (Diluted)	-8.76	-8.73	-9.29
Free Cash Flow	-11.84	-7.36	-3.53
Free Cash Flow Per Share	-6.74	-6.04	-3.93
EBITDA	-14.67	-10.96	-7.63
EBIT	-14.67	-10.96	-7.63

Updated Nov 10, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q